Dendritic skin cells

Expert Review of Dermatology

Volumn 3, Issue 4, 2008, Pages 509-515

  Carneiro, Sueli Coelho ^a,b   Medeiros, Raphael ^c   Brollo, Marcelo Alves ^a   Ramos e Silva, Marcia ^a   Sotto, Mirian Nacagami ^c  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Dendritic cells; Dermal dendrocytes; Langerhans cells

Indexed keywords

AUTOANTIGEN; CD36 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CHEMOKINE; CYTOKINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; T LYMPHOCYTE RECEPTOR;

ANTIGEN PRESENTING CELL; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CELL MATURATION; CELLULAR IMMUNITY; CYTOKINE RELEASE; DENDRITIC CELL; HUMAN; IMMUNOGENICITY; IMMUNOREGULATION; LYMPH NODE; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE MIGRATION; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; SKIN CELL; SKIN DISEASE; T LYMPHOCYTE ACTIVATION;

EID: 55349117097     PISSN: 17469872     EISSN: None     Source Type: Journal    
DOI: 10.1586/17469872.3.4.509     Document Type: Review

References (43)

1. Headington JT. The dermal dendrocyte. Adv. Dermatol. 1, 159-171 (1986).
2. Cerio R, Griffiths CE, Cooper KD, Nickoloff BJ, Headington JT. Characterization of factor XIIIa positive dermal dendritic cells in normal and inflamed skin. Br. J. Dermatol. 121(4), 421-431 (1989).
3. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 392(6673), 245-252 (1998).
4. Banchereau J, Briere F, Caux C et al. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18, 767-811 (2000).
5. Steinman RM. Some interfaces of dendritic cell biology. APIMS 111(7-8), 675-697 (2003).
6. Shortman K, Liu YJ. Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2(3), 151-161 (2002).
7. Freudenthal PS, Steinman RM. The distinct surface of human blood dendritic cells, as observed after an improved isolation method. Proc. Natl Acad. Sci. USA 87(19), 7698-7702 (1990).
8. Guermonprez P, Valladeau J, Zitvogel L, Théry C, Amigorena S. Antigen presentation and T cell stimulation by dendritic cells. Annu. Rev. Immunol. 20, 621-667 (2002).
9. Wollenberg A, Wagner M, Gunther S et al. Plasmacytoid dendritic cells: a new cutaneous dendritic cell subset with distinct role in inflammatory skin diseases. J. Invest. Dermatol. 119(5), 1096-1102 (2002).
10. Jakob T, Udey MC. Epidermal Langerhans cells: from neurons to nature's adjuvants. Adv. Dermatol. 14, 209-258 (1999).
11. Valladeau J, Ravel O, Dezutter-Dambuyant C et al. Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules. Immunity 12(1), 71-81 (2000).
12. + perivascular dendritic cells. J. Invest. Dermatol. 96(3), 3330-3340 (1991).
13. + hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to granulocyte-macrophage colony-stimulating factor plus tumor necrosis factor α: II. Functional analysis. Blood 90(4), 1458-1470 (1997).
14. Lipscomb MF, Masten BJ. Dendritic cells: immune regulators in health and disease. Physiol. Rev. 82(1), 97-130 (2002).
15. Liu YJ. IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu. Rev. Immunol. 23, 275-306 (2005).
16. Steinman RM, Banchereau J. Taking dendritic cells into medicine. Nature 449(7161), 419-426 (2007).
17. Heath WR, Carbone FR. Cross-presentation, dendritic cells, tolerance and immunity. Annu. Rev. Immunol. 19, 47-64 (2001).
18. Heath WR, Belz GT, Behrens GM et al. Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens. Immunol. Rev. 199, 9-26 (2004).
19. Früh K, Ahn K, Djaballah H et al. A viral inhibitor of peptide transporters for antigen presentation. Nature 375(6530), 415-418 (1995).
20. - dendritic cells in vivo. J. Exp. Med. 196(6), 817-827 (2002).
21. + T cells engaging class II molecules in cholesterol-rich domains. J. Immunol. 168(3), 1172-80 (2002).
22. Datta SK, Redecke V, Prilliman KR et al. A subset of Toll-like receptor ligands induces cross-presentation by bone marrow-derived dendritic cells. J. Immunol. 170(8), 4102-4110 (2003).
23. Delamarre L, Holcombe H, Mellman L. Presentation of exogenous antigens on major histocompatibility complex (MHC) class I and MHC class II molecules is differentially regulated during dendritic cell maturation. J. Exp. Med. 198(1), 111-22 (2003).
24. Hotta C, Fujimaki H, Yoshinari M, Nakazawa M, Minami M. The delivery of an antigen from the endocytic compartment into the cytosol for cross-presentation is restricted to early immature dendritic cells. Immunology 117(1), 97-107 (2006).
25. Pulendran B, Palucka K, Banchereau J. Sensing pathogens and tuning immune responses. Science 293 (5528), 253-256 (2001).
26. Akira S, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2(8), 675-680 (2001).
27. McColl SR. Chemokines and dendritic cells: a crucial alliance. Immunol. Cell Biol. 80(5), 489-496 (2002).
28. Porcelli SA, Modlin RL. The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids. Annu. Rev. Immunol. 17, 297-329 (1999).
29. Steinman RM, Nussenzweig MC. Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc. Natl Acad. Sci. USA 99(1), 351-358 (2002).
30. Benvenuti F, Lagaudriere-Gesbert C, Grandjean I et al. Dendritic cell maturation controls adhesion, synapse formation, and the duration of the interactions with naive T lymphocytes. J. Immunol. 172(1), 292-301 (2004).
31. Zwickey HL, Unternaehrer JJ, Mellman I. Presentation of self-antigens on MHC class II molecules during dendritic cell maturation. Int. Immunol. 18(1), 199-209 (2006).
32. Baggiolini M. Chemokines and leukocyte traffic. Nature 392(6676), 565-568 (1998).
33. Saeki H, Moore AM, Brown MJ, Hwang ST. Cutting edge: secondary lymphoid-tissue chemokine (SLC) and CC chemokine receptor 7 (CCR7) participate in the emigration pathway of mature dendritic cells from the skin to regional lymph nodes. J. Immunol. 162(5), 2472-2475 (1999).
34. Gunn MD, Kyuwa S, Tam C et al. Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J. Exp. Med. 189(3), 451-460 (1999).
35. Gunn MD. Chemokine mediated control of dendritic cell migration and function. Semin. Immunol. 15(5), 271-276 (2003).
36. McHugh RS, Shevach EM. The role of suppressor T cells in regulation of immune responses. J. Allergy Clin. Immunol. 110(5), 693-702 (2002).
37. + suppressor T cells: more questions than answers. Nat. Rev. Immunol. 2(6), 389-400 (2002).
38. Mahnke K, Schmitt E, Bonifaz L, Enk AH, Jonuleit H. Immature, but not inactive: the tolerogenic function of immatue dendritic cells. Immunol. Cell Biol. 80(5), 477-483 (2002).
39. Geissmann F, Dieu-Nosjean MC, Dezutter C et al. Accumulation of immature Langerhans cells in human lymph nodes draining chronically inflamed skin. J. Exp. Med. 196(4), 417-430 (2002).
40. Casciola-Rosen LA, Anhalt G, Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J. Exp. Med. 179(4), 1317-1330 (1994).
41. Matzinger P. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12, 991-1045 (1994).
42. Lutz MB, Schuler G. Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol. 23(9), 445-449 (2002).
43. Vremec D, Shortman K. Dendritic cell subtypes in mouse lymphoid organs cross-correlation of surface markers, changes with incubation, and differences among thymus, spleen, and lymph nodes. J. Immunol. 159(2), 565-573 (1997).